A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for human transplantation. . . . → Read More: Gene-Edited Transplant Organ Company Raises $125M
|
|||||
A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for human transplantation. . . . → Read More: Gene-Edited Transplant Organ Company Raises $125M A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand. . . . → Read More: Crispr-Edited Bananas Get Industry Funding One of the more pressing concerns is the development of propagation methods that meet the requirements of mass production. . . . → Read More: Tissue Culture: A Novel Propagation Method for Cannabis Industry A new challenge competition from XPrize is looking for alternatives to chicken and fish that look and taste like the real thing, but are friendlier to the planet. . . . → Read More: Challenge Seeks Sustainable Chicken, Fish Alternatives A small silicon lab-on-a-chip device costing about $0.35 to make is shown in lab tests to quickly detect SARS-CoV-2 viruses and infectious bacteria. . . . → Read More: Inexpensive Chip Detects Covid-19, Other Pathogens An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits A California energy utility and Salk Institute are collaborating on engineering new plant varieties that capture and store more carbon dioxide in the ground. . . . → Read More: Salk, Energy Utility Partner on Carbon Capture Plants The genome of the Asian giant hornet, a species threatening bees and humans, was analyzed, with the data released by the Agricultural Research Service. . . . → Read More: Giant Hornet Genome Sequenced A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology. . . . → Read More: Venture Fund Plans $350M for Biotech Start-Ups A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza. . . . → Read More: Trial Underway for Seasonal Flu Antibody Therapy |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |